Phase I/II, Randomized, Observer-Blind, Placebo-Controlled, Single-Center Study of the Tolerability, Immunogenicity, and Efficacy of an Novartis' Investigational H. Pylori Vaccine in H. Pylori-Negative Adults.

Trial Profile

Phase I/II, Randomized, Observer-Blind, Placebo-Controlled, Single-Center Study of the Tolerability, Immunogenicity, and Efficacy of an Novartis' Investigational H. Pylori Vaccine in H. Pylori-Negative Adults.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs Helicobacter pylori vaccine (Primary)
  • Indications Helicobacter pylori infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 May 2012 Phase II results presented at Digestive Disease Week 2012.
    • 19 May 2010 Actual patient number added as 63 as reported by ClinicalTrials.gov.
    • 19 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top